Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. Important factors that could cause actual results to differ materially from the Company's expectations including the risks detailed from time to time in the Company's public disclosure. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. ![]() All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. This news release contains forward-looking statements. Novamind stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Novamind. For every potential investor in Novamind, whether a beginner or expert, Novamind's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. The Company enables access to psychedelic medicine through a network of clinics, retreats and clinical research sites. Novamind Inc., formerly Hinterland Metals Inc., is a Canada-based mental health company. Support for the NovaMind iOS and Android apps will be suspended immediately, and NovaMind Cloud will be shut. In a statement on the NovaMind home page, Klug says he plans to continue development of the Mac and PC versions of the program. The transaction is expected to close in June following special meetings of shareholders of both companies.The new owner, Patrick Klug, is a former NovaMind developer who worked extensively on the NovaMind 5 release. After the transaction, Novamind shareholders would hold about 18% of the company on a pro-forma, fully diluted basis. The offer price represents a premium of 51% to Novamind’s 20-day volume-weighted average price on the Canadian Securities Exchange. ![]() Under the accord, shareholders of Novamind would receive 0.84 of a common share of Numinus for each Novamind share held, implying an offer price of 44 cents per Novamind Share. Yaron Conforti, CEO of Novamind, said the combined entity is supported with more than $50-million (Canadian) in pro-forma capital and positioned with distinct capabilities to serve a growing and diverse group of stakeholders. “We expect this acquisition will significantly bolster our financial performance, growing Numinus’ annual revenue to more than five times our current levels, and driving meaningful margin improvement through identified operating efficiencies,” he added. platform through eight established, reputable, efficiently operating and revenue-producing clinics,” Payton Nyquvest, CEO of Numinus, said in a statement. “The Novamind acquisition presents a transformational opportunity for Numinus to launch a strong U.S. ![]() The combined company will operate 13 wellness clinics and will be positioned as a leading psychedelic-assisted therapy provider in North America, leading its peer group in revenue with approximately $10-million (Canadian) in annual pro-forma revenue based on the trailing four quarters. Numinus (TSX:NUMI OTCQX:NUMIF) agreed to acquire Novamind (CSE:NM OTCQB:NVMDF FSE:HN2) in a stock swap, by way of a court-approved plan of arrangement, for total consideration of about $26.2-million (Canadian).
0 Comments
Leave a Reply. |